PTSD VR Therapy Market Forecasts to 2032 – Global Analysis By Type (Exposure Therapy, Cognitive Behavioral Therapy, Eye Movement Desensitization and Reprocessing, Biofeedback-augmented VR therapy, Combined / Hybrid Therapy Models and Other Types), Compone
Description
According to Stratistics MRC, the Global PTSD VR Therapy Market is accounted for $1.74 billion in 2025 and is expected to reach $5.49 billion by 2032 growing at a CAGR of 17.8% during the forecast period. PTSD VR therapy is a technology-driven treatment that uses immersive virtual reality environments to help individuals confront and process traumatic experiences in a controlled, therapeutic setting. By simulating realistic scenarios tailored to the patient’s trauma, it facilitates exposure therapy, emotional regulation, and cognitive restructuring. This method enhances engagement, reduces avoidance behaviors, and supports gradual desensitization. Clinicians monitor responses and adjust stimuli to optimize outcomes, making VR therapy a promising tool for personalized, evidence-based care in post-traumatic stress disorder management.
According to International Journal of Environmental Research and Public Health, Virtual Reality-Based Graded Exposure Therapy (VR-GET) demonstrated a significantly larger effect size for reducing PTSD symptoms.
Market Dynamics:
Driver:
Rapid evolution of VR hardware & proven clinical efficacy
Clinical studies have demonstrated measurable improvements in PTSD symptoms through exposure therapy conducted in VR environments, validating its therapeutic potential. Integration with biometric sensors and AI-driven feedback loops is further elevating treatment personalization. As healthcare providers seek scalable and non-invasive solutions, VR therapy is gaining traction as a viable alternative to traditional methods. These innovations are enhancing therapeutic realism and patient engagement, making VR-based interventions more effective boosting the market growth.
Restraint:
Limited evidence for diverse populations
Most trials have focused on military veterans or specific trauma cohorts, leaving gaps in understanding efficacy among children, elderly patients, and culturally diverse populations. This lack of inclusive data limits broader adoption and raises concerns about generalizability. Additionally, language barriers and cultural nuances in trauma response may affect the effectiveness of standardized VR modules. Without robust, peer-reviewed studies encompassing global populations, regulatory approvals and insurance reimbursements remain constrained.
Opportunity:
Expansion into broader mental health
Beyond PTSD, VR therapy is showing potential in addressing a wider spectrum of mental health conditions such as anxiety disorders, phobias, depression, and substance abuse. The modular nature of VR platforms allows for rapid adaptation of therapeutic content to suit different psychological needs. As mental health awareness grows globally, demand for accessible, tech-enabled interventions is surging. Institutions are exploring VR for group therapy, mindfulness training, and cognitive rehabilitation, opening new revenue streams positioning VR as a cornerstone of next-generation behavioral healthcare.
Threat:
Competition from established therapies
The novelty, of VR therapy must contend with entrenched treatment modalities like pharmacotherapy, cognitive behavioral therapy (CBT), and EMDR (Eye Movement Desensitization and Reprocessing). These approaches have decades of clinical validation and widespread practitioner familiarity, making them the default choice for many providers. Moreover, reimbursement frameworks and clinical guidelines often favor conventional therapies, limiting VR’s market penetration. Skepticism among clinicians regarding long-term efficacy and cost-effectiveness of VR solutions may further slow adoption.
Covid-19 Impact:
The pandemic accelerated interest in remote and digital mental health solutions, including VR-based PTSD therapy. Lockdowns and social distancing measures disrupted in-person counseling, prompting providers to explore immersive technologies for continuity of care. VR platforms enabled patients to undergo exposure therapy from home, reducing barriers to access and enhancing treatment adherence. However, supply chain disruptions affected hardware availability, and economic uncertainty limited institutional investments in new technologies.
The cognitive behavioral therapy segment is expected to be the largest during the forecast period
The cognitive behavioral therapy segment is expected to account for the largest market share during the forecast period due to its structured, evidence-based approach that aligns well with VR delivery. CBT modules can be effectively translated into immersive scenarios, allowing patients to confront and reframe traumatic memories in a controlled environment. The adaptability of CBT to various trauma types and its compatibility with digital platforms make it a preferred choice among clinicians.
The post-traumatic stress disorder (PTSD) segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the post-traumatic stress disorder (PTSD) segment is predicted to witness the highest growth rate driven by increasing awareness and diagnosis of trauma-related conditions. Rising incidences of PTSD among civilians, first responders, and healthcare workers are expanding the target population. VR therapy offers a non-invasive, stigma-free alternative to traditional counseling, making it particularly appealing for younger demographics. Continued research into trauma-specific VR modules and growing institutional support for mental health initiatives are fueling market expansion.
Region with largest share:
During the forecast period, the Asia Pacific region is expected to hold the largest market share propelled by rising mental health awareness and expanding access to digital healthcare infrastructure. Countries like China, Japan, and South Korea are investing heavily in VR technologies and integrating them into public health systems. Government-backed initiatives promoting mental wellness and trauma recovery are creating favorable conditions for market growth.
Region with highest CAGR:
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR attributed to robust healthcare infrastructure, early adoption of emerging technologies, and strong presence of VR therapy startups. The region benefits from favorable reimbursement policies, active research funding, and a high prevalence of PTSD cases, particularly among veterans. Collaborations between tech companies and academic institutions are accelerating innovation, while regulatory bodies are increasingly recognizing VR as a legitimate therapeutic tool.
Key players in the market
Some of the key players in PTSD VR Therapy Market include XRHealth, AppliedVR, Limbix, Psious, MyndVR, KindVR, Corpus VR, Cognihab, RelieVRx, Virtually Better, Neuro Rehab VR, PsyTech VR, oVRcome, Floreo, BehaVR, Oxford VR, and Enosis Therapeutics.
Key Developments:
In July 2025, PsyTech VR published a v2.0.7 product update announcing enhanced AI tools and also showcased at ACBS World Conference. The June update described incremental product improvements to treatment protocols and clinician tooling; conference presence (July) promoted clinical adoption.
In June 2025, Floreo announced the launch of a Scientific Advisory Board to advance evidence-based VR therapy for neurodivergent learners. Additionally, Floreo was selected by Center for Social Dynamics to expand VR ABA services in U.S. schools
In April 2025, Mynd Immersive announced an expansion delivering VR therapeutics to >150 U.S. senior-living communities. The release highlights partnerships (e.g., Select Rehabilitation, HTC VIVE, AT&T) to scale immersive therapeutics across senior care and post-acute settings.
Types Covered:
• Exposure Therapy
• Cognitive Behavioral Therapy
• Eye Movement Desensitization and Reprocessing
• Biofeedback-augmented VR therapy
• Combined / Hybrid Therapy Models
• Other Types
Components Covered:
• Hardware
• Software
• Services
• Other Components
Modalities Covered:
• Immersive VR
• Semi-Immersive
• Non-Immersive
Applications Covered:
• Depression
• Anxiety Disorders
• Post-Traumatic Stress Disorder (PTSD)
• Pain Management
• Addiction Management
• Other Applications
End Users Covered:
• Therapy Clinics & Rehabilitation Centers
• Military & Defense
• Hospitals & Clinics
• Research & Academic Institutions
• Homecare Settings
• Other End Users
Regions Covered:
• North America
US
Canada
Mexico
• Europe
Germany
UK
Italy
France
Spain
Rest of Europe
• Asia Pacific
Japan
China
India
Australia
New Zealand
South Korea
Rest of Asia Pacific
• South America
Argentina
Brazil
Chile
Rest of South America
• Middle East & Africa
Saudi Arabia
UAE
Qatar
South Africa
Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
• Company Profiling
Comprehensive profiling of additional market players (up to 3)
SWOT Analysis of key players (up to 3)
• Regional Segmentation
Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
According to International Journal of Environmental Research and Public Health, Virtual Reality-Based Graded Exposure Therapy (VR-GET) demonstrated a significantly larger effect size for reducing PTSD symptoms.
Market Dynamics:
Driver:
Rapid evolution of VR hardware & proven clinical efficacy
Clinical studies have demonstrated measurable improvements in PTSD symptoms through exposure therapy conducted in VR environments, validating its therapeutic potential. Integration with biometric sensors and AI-driven feedback loops is further elevating treatment personalization. As healthcare providers seek scalable and non-invasive solutions, VR therapy is gaining traction as a viable alternative to traditional methods. These innovations are enhancing therapeutic realism and patient engagement, making VR-based interventions more effective boosting the market growth.
Restraint:
Limited evidence for diverse populations
Most trials have focused on military veterans or specific trauma cohorts, leaving gaps in understanding efficacy among children, elderly patients, and culturally diverse populations. This lack of inclusive data limits broader adoption and raises concerns about generalizability. Additionally, language barriers and cultural nuances in trauma response may affect the effectiveness of standardized VR modules. Without robust, peer-reviewed studies encompassing global populations, regulatory approvals and insurance reimbursements remain constrained.
Opportunity:
Expansion into broader mental health
Beyond PTSD, VR therapy is showing potential in addressing a wider spectrum of mental health conditions such as anxiety disorders, phobias, depression, and substance abuse. The modular nature of VR platforms allows for rapid adaptation of therapeutic content to suit different psychological needs. As mental health awareness grows globally, demand for accessible, tech-enabled interventions is surging. Institutions are exploring VR for group therapy, mindfulness training, and cognitive rehabilitation, opening new revenue streams positioning VR as a cornerstone of next-generation behavioral healthcare.
Threat:
Competition from established therapies
The novelty, of VR therapy must contend with entrenched treatment modalities like pharmacotherapy, cognitive behavioral therapy (CBT), and EMDR (Eye Movement Desensitization and Reprocessing). These approaches have decades of clinical validation and widespread practitioner familiarity, making them the default choice for many providers. Moreover, reimbursement frameworks and clinical guidelines often favor conventional therapies, limiting VR’s market penetration. Skepticism among clinicians regarding long-term efficacy and cost-effectiveness of VR solutions may further slow adoption.
Covid-19 Impact:
The pandemic accelerated interest in remote and digital mental health solutions, including VR-based PTSD therapy. Lockdowns and social distancing measures disrupted in-person counseling, prompting providers to explore immersive technologies for continuity of care. VR platforms enabled patients to undergo exposure therapy from home, reducing barriers to access and enhancing treatment adherence. However, supply chain disruptions affected hardware availability, and economic uncertainty limited institutional investments in new technologies.
The cognitive behavioral therapy segment is expected to be the largest during the forecast period
The cognitive behavioral therapy segment is expected to account for the largest market share during the forecast period due to its structured, evidence-based approach that aligns well with VR delivery. CBT modules can be effectively translated into immersive scenarios, allowing patients to confront and reframe traumatic memories in a controlled environment. The adaptability of CBT to various trauma types and its compatibility with digital platforms make it a preferred choice among clinicians.
The post-traumatic stress disorder (PTSD) segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the post-traumatic stress disorder (PTSD) segment is predicted to witness the highest growth rate driven by increasing awareness and diagnosis of trauma-related conditions. Rising incidences of PTSD among civilians, first responders, and healthcare workers are expanding the target population. VR therapy offers a non-invasive, stigma-free alternative to traditional counseling, making it particularly appealing for younger demographics. Continued research into trauma-specific VR modules and growing institutional support for mental health initiatives are fueling market expansion.
Region with largest share:
During the forecast period, the Asia Pacific region is expected to hold the largest market share propelled by rising mental health awareness and expanding access to digital healthcare infrastructure. Countries like China, Japan, and South Korea are investing heavily in VR technologies and integrating them into public health systems. Government-backed initiatives promoting mental wellness and trauma recovery are creating favorable conditions for market growth.
Region with highest CAGR:
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR attributed to robust healthcare infrastructure, early adoption of emerging technologies, and strong presence of VR therapy startups. The region benefits from favorable reimbursement policies, active research funding, and a high prevalence of PTSD cases, particularly among veterans. Collaborations between tech companies and academic institutions are accelerating innovation, while regulatory bodies are increasingly recognizing VR as a legitimate therapeutic tool.
Key players in the market
Some of the key players in PTSD VR Therapy Market include XRHealth, AppliedVR, Limbix, Psious, MyndVR, KindVR, Corpus VR, Cognihab, RelieVRx, Virtually Better, Neuro Rehab VR, PsyTech VR, oVRcome, Floreo, BehaVR, Oxford VR, and Enosis Therapeutics.
Key Developments:
In July 2025, PsyTech VR published a v2.0.7 product update announcing enhanced AI tools and also showcased at ACBS World Conference. The June update described incremental product improvements to treatment protocols and clinician tooling; conference presence (July) promoted clinical adoption.
In June 2025, Floreo announced the launch of a Scientific Advisory Board to advance evidence-based VR therapy for neurodivergent learners. Additionally, Floreo was selected by Center for Social Dynamics to expand VR ABA services in U.S. schools
In April 2025, Mynd Immersive announced an expansion delivering VR therapeutics to >150 U.S. senior-living communities. The release highlights partnerships (e.g., Select Rehabilitation, HTC VIVE, AT&T) to scale immersive therapeutics across senior care and post-acute settings.
Types Covered:
• Exposure Therapy
• Cognitive Behavioral Therapy
• Eye Movement Desensitization and Reprocessing
• Biofeedback-augmented VR therapy
• Combined / Hybrid Therapy Models
• Other Types
Components Covered:
• Hardware
• Software
• Services
• Other Components
Modalities Covered:
• Immersive VR
• Semi-Immersive
• Non-Immersive
Applications Covered:
• Depression
• Anxiety Disorders
• Post-Traumatic Stress Disorder (PTSD)
• Pain Management
• Addiction Management
• Other Applications
End Users Covered:
• Therapy Clinics & Rehabilitation Centers
• Military & Defense
• Hospitals & Clinics
• Research & Academic Institutions
• Homecare Settings
• Other End Users
Regions Covered:
• North America
US
Canada
Mexico
• Europe
Germany
UK
Italy
France
Spain
Rest of Europe
• Asia Pacific
Japan
China
India
Australia
New Zealand
South Korea
Rest of Asia Pacific
• South America
Argentina
Brazil
Chile
Rest of South America
• Middle East & Africa
Saudi Arabia
UAE
Qatar
South Africa
Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
• Company Profiling
Comprehensive profiling of additional market players (up to 3)
SWOT Analysis of key players (up to 3)
• Regional Segmentation
Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
200 Pages
- 1 Executive Summary
- 2 Preface
- 2.1 Abstract
- 2.2 Stake Holders
- 2.3 Research Scope
- 2.4 Research Methodology
- 2.4.1 Data Mining
- 2.4.2 Data Analysis
- 2.4.3 Data Validation
- 2.4.4 Research Approach
- 2.5 Research Sources
- 2.5.1 Primary Research Sources
- 2.5.2 Secondary Research Sources
- 2.5.3 Assumptions
- 3 Market Trend Analysis
- 3.1 Introduction
- 3.2 Drivers
- 3.3 Restraints
- 3.4 Opportunities
- 3.5 Threats
- 3.6 Application Analysis
- 3.7 End User Analysis
- 3.8 Emerging Markets
- 3.9 Impact of Covid-19
- 4 Porters Five Force Analysis
- 4.1 Bargaining power of suppliers
- 4.2 Bargaining power of buyers
- 4.3 Threat of substitutes
- 4.4 Threat of new entrants
- 4.5 Competitive rivalry
- 5 Global PTSD VR Therapy Market, By Type
- 5.1 Introduction
- 5.2 Exposure Therapy
- 5.3 Cognitive Behavioral Therapy
- 5.4 Eye Movement Desensitization and Reprocessing
- 5.5 Biofeedback-augmented VR therapy
- 5.6 Combined / Hybrid Therapy Models
- 5.7 Other Types
- 6 Global PTSD VR Therapy Market, By Component
- 6.1 Introduction
- 6.2 Hardware
- 6.2.1 Head-Mounted Displays (HMDs)
- 6.2.2 Controllers & Tracking Systems
- 6.2.3 Physiological Sensors
- 6.2.4 Haptics & peripherals
- 6.3 Software
- 6.3.1 Simulation Content & Scenario Libraries
- 6.3.2 Clinical Management & Analytics Software
- 6.4 Services
- 6.4.1 Software Customization & Integration Services
- 6.4.2 Clinical Implementation & Therapist Training
- 6.4.3 Maintenance & Support
- 6.5 Other Components
- 7 Global PTSD VR Therapy Market, By Modality
- 7.1 Introduction
- 7.2 Immersive VR
- 7.3 Semi-Immersive
- 7.4 Non-Immersive
- 8 Global PTSD VR Therapy Market, By Application
- 8.1 Introduction
- 8.2 Depression
- 8.3 Anxiety Disorders
- 8.4 Post-Traumatic Stress Disorder (PTSD)
- 8.5 Pain Management
- 8.6 Addiction Management
- 8.7 Other Applications
- 9 Global PTSD VR Therapy Market, By End User
- 9.1 Introduction
- 9.2 Therapy Clinics & Rehabilitation Centers
- 9.3 Military & Defense
- 9.4 Hospitals & Clinics
- 9.5 Research & Academic Institutions
- 9.6 Homecare Settings
- 9.7 Other End Users
- 10 Global PTSD VR Therapy Market, By Geography
- 10.1 Introduction
- 10.2 North America
- 10.2.1 US
- 10.2.2 Canada
- 10.2.3 Mexico
- 10.3 Europe
- 10.3.1 Germany
- 10.3.2 UK
- 10.3.3 Italy
- 10.3.4 France
- 10.3.5 Spain
- 10.3.6 Rest of Europe
- 10.4 Asia Pacific
- 10.4.1 Japan
- 10.4.2 China
- 10.4.3 India
- 10.4.4 Australia
- 10.4.5 New Zealand
- 10.4.6 South Korea
- 10.4.7 Rest of Asia Pacific
- 10.5 South America
- 10.5.1 Argentina
- 10.5.2 Brazil
- 10.5.3 Chile
- 10.5.4 Rest of South America
- 10.6 Middle East & Africa
- 10.6.1 Saudi Arabia
- 10.6.2 UAE
- 10.6.3 Qatar
- 10.6.4 South Africa
- 10.6.5 Rest of Middle East & Africa
- 11 Key Developments
- 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
- 11.2 Acquisitions & Mergers
- 11.3 New Product Launch
- 11.4 Expansions
- 11.5 Other Key Strategies
- 12 Company Profiling
- 12.1 XRHealth
- 12.2 AppliedVR
- 12.3 Limbix
- 12.4 Psious
- 12.5 MyndVR
- 12.6 KindVR
- 12.7 Corpus VR
- 12.8 Cognihab
- 12.9 RelieVRx
- 12.10 Virtually Better
- 12.11 Neuro Rehab VR
- 12.12 PsyTech VR
- 12.13 oVRcome
- 12.14 Floreo
- 12.15 BehaVR
- 12.16 Oxford VR
- 12.17 Enosis Therapeutics
- List of Tables
- Table 1 Global PTSD VR Therapy Market Outlook, By Region (2024-2032) ($MN)
- Table 2 Global PTSD VR Therapy Market Outlook, By Type (2024-2032) ($MN)
- Table 3 Global PTSD VR Therapy Market Outlook, By Exposure Therapy (2024-2032) ($MN)
- Table 4 Global PTSD VR Therapy Market Outlook, By Cognitive Behavioral Therapy (2024-2032) ($MN)
- Table 5 Global PTSD VR Therapy Market Outlook, By Eye Movement Desensitization and Reprocessing (2024-2032) ($MN)
- Table 6 Global PTSD VR Therapy Market Outlook, By Biofeedback-augmented VR therapy (2024-2032) ($MN)
- Table 7 Global PTSD VR Therapy Market Outlook, By Combined / Hybrid Therapy Models (2024-2032) ($MN)
- Table 8 Global PTSD VR Therapy Market Outlook, By Other Types (2024-2032) ($MN)
- Table 9 Global PTSD VR Therapy Market Outlook, By Component (2024-2032) ($MN)
- Table 10 Global PTSD VR Therapy Market Outlook, By Hardware (2024-2032) ($MN)
- Table 11 Global PTSD VR Therapy Market Outlook, By Head-Mounted Displays (HMDs) (2024-2032) ($MN)
- Table 12 Global PTSD VR Therapy Market Outlook, By Controllers & Tracking Systems (2024-2032) ($MN)
- Table 13 Global PTSD VR Therapy Market Outlook, By Physiological Sensors (2024-2032) ($MN)
- Table 14 Global PTSD VR Therapy Market Outlook, By Haptics & peripherals (2024-2032) ($MN)
- Table 15 Global PTSD VR Therapy Market Outlook, By Software (2024-2032) ($MN)
- Table 16 Global PTSD VR Therapy Market Outlook, By Simulation Content & Scenario Libraries (2024-2032) ($MN)
- Table 17 Global PTSD VR Therapy Market Outlook, By Clinical Management & Analytics Software (2024-2032) ($MN)
- Table 18 Global PTSD VR Therapy Market Outlook, By Services (2024-2032) ($MN)
- Table 19 Global PTSD VR Therapy Market Outlook, By Software Customization & Integration Services (2024-2032) ($MN)
- Table 20 Global PTSD VR Therapy Market Outlook, By Clinical Implementation & Therapist Training (2024-2032) ($MN)
- Table 21 Global PTSD VR Therapy Market Outlook, By Maintenance & Support (2024-2032) ($MN)
- Table 22 Global PTSD VR Therapy Market Outlook, By Other Components (2024-2032) ($MN)
- Table 23 Global PTSD VR Therapy Market Outlook, By Modality (2024-2032) ($MN)
- Table 24 Global PTSD VR Therapy Market Outlook, By Immersive VR (2024-2032) ($MN)
- Table 25 Global PTSD VR Therapy Market Outlook, By Semi-Immersive (2024-2032) ($MN)
- Table 26 Global PTSD VR Therapy Market Outlook, By Non-Immersive (2024-2032) ($MN)
- Table 27 Global PTSD VR Therapy Market Outlook, By Application (2024-2032) ($MN)
- Table 28 Global PTSD VR Therapy Market Outlook, By Depression (2024-2032) ($MN)
- Table 29 Global PTSD VR Therapy Market Outlook, By Anxiety Disorders (2024-2032) ($MN)
- Table 30 Global PTSD VR Therapy Market Outlook, By Post-Traumatic Stress Disorder (PTSD) (2024-2032) ($MN)
- Table 31 Global PTSD VR Therapy Market Outlook, By Pain Management (2024-2032) ($MN)
- Table 32 Global PTSD VR Therapy Market Outlook, By Addiction Management (2024-2032) ($MN)
- Table 33 Global PTSD VR Therapy Market Outlook, By Other Applications (2024-2032) ($MN)
- Table 34 Global PTSD VR Therapy Market Outlook, By End User (2024-2032) ($MN)
- Table 35 Global PTSD VR Therapy Market Outlook, By Therapy Clinics & Rehabilitation Centers (2024-2032) ($MN)
- Table 36 Global PTSD VR Therapy Market Outlook, By Military & Defense (2024-2032) ($MN)
- Table 37 Global PTSD VR Therapy Market Outlook, By Hospitals & Clinics (2024-2032) ($MN)
- Table 38 Global PTSD VR Therapy Market Outlook, By Research & Academic Institutions (2024-2032) ($MN)
- Table 39 Global PTSD VR Therapy Market Outlook, By Homecare Settings (2024-2032) ($MN)
- Table 40 Global PTSD VR Therapy Market Outlook, By Other End Users (2024-2032) ($MN)
- Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.